RO Group, the family-owned investment company, sold 56 Clarendon Road in Watford to Strides Pharma UK for a 40% premium on the property’s 2025 valuation.
RO acquired the property in 2014 and the recent sale represents the realisation of a long-term investment. It is understood that the group will seek to reinvest the liquidated capital into the roadside and industrial sectors in the Midlands and South of England.
A spokesperson for RO said the sale outlines ‘the Group’s value-driven approach to managing and unlocking potential across its portfolio’.
Strides Pharma will use 56 Clarendon Road as their new headquarters. Watford is already home to many national and multinational companies, particularly along Clarendon Road, including KPMG, Ralph Lauren, TJX Europe, PwC, Allwyn and Epson.
Nick Cashmore, investment director at RO Real Estate, said: “We are delighted to announce the sale of 56 Clarendon Road to Strides Pharma, a multinational pharmaceutical company, and to see the building become its new UK headquarters. The opportunistic sale represents a well-timed realisation with the sale price reflecting a 40% premium on the 2025 valuation.”
The RO Group was advised by Womble Bond Dickinson and Brasier Freeth on this transaction.
Image: RO Group
© Eastern Echo (powered by ukpropertyforums.com).
This article and its contents are the intellectual property of UK Property Forums and may not be reproduced, distributed, or used in any form without prior written permission. The views expressed are those of the author(s) and do not constitute legal or professional advice.
